How to Document Sleep Medicine Evaluations and Polysomnography Reports

A practical guide for sleep medicine physicians, NPs, and PAs covering initial sleep consultations, PSG interpretation reports, CPAP titration documentation, home sleep tests, MSLT/MWT studies, and CMS requirements for DME orders.

Sleep medicine documentation sits at an unusual intersection of objective data, clinical interpretation, and payer compliance. A polysomnography (PSG) report is not just a summary of overnight sensor readings. It is a clinical interpretation document that must justify diagnoses, support treatment decisions, and satisfy CMS requirements for durable medical equipment orders. A standard office visit note written without attention to sleep-specific data points will fail on all three counts.

This guide covers the documentation workflow for the full sleep medicine encounter cycle: initial consultation, PSG and home sleep test reports, CPAP and BiPAP titration notes, MSLT and MWT documentation, follow-up visit structure, and the payer requirements that tie it all together.

Why Sleep Medicine Documentation Is Different

Most specialties organize notes around a chief complaint, physical exam, and assessment. Sleep medicine adds a layer of technical data interpretation that most note templates do not handle well. You are simultaneously:

Translating raw polysomnographic data into clinically meaningful findings
Documenting the basis for a specific diagnosis (not just a symptom)
Establishing the medical necessity for equipment that payers scrutinize closely
Creating a longitudinal record across study types (diagnostic PSG, titration PSG, HST, MSLT, follow-up)

When these pieces are not documented with enough specificity, prior authorization denials pile up, DME orders get rejected, and patients wait weeks longer than they should for treatment.

The Initial Sleep Consultation Note

The initial consultation establishes the clinical foundation for every study and intervention that follows. A thorough consultation note for a sleep medicine referral includes:

Chief complaint and sleep history: Document the presenting symptom in the patient's own language first ("I wake up choking almost every night"), then translate it into clinical terms. Capture sleep-onset latency, sleep maintenance difficulty, early morning awakening, and total sleep time estimates. For suspected obstructive sleep apnea (OSA), document the STOP-BANG score with each item answered individually, not just a total score.

Daytime symptom documentation: The Epworth Sleepiness Scale (ESS) is the standard self-report instrument. Document the total score (0-24), flag scores above 10 as indicating excessive daytime sleepiness, and note whether the score has changed since a prior visit if this is a follow-up. The ESS alone does not establish a diagnosis, but it quantifies functional impairment, which is exactly what payers want to see for medical necessity.

Sleep diary review: If the patient completed a two-week sleep diary prior to the consultation, summarize the pattern rather than copying every entry. Note average total time in bed, average estimated total sleep time, sleep efficiency percentage, and any pattern of variable vs consistent sleep timing. This becomes especially important when evaluating for circadian rhythm sleep-wake disorders.

Sleepiness vs fatigue distinction: Document this explicitly. Patients with insomnia often describe fatigue without the ability to fall asleep involuntarily; patients with hypersomnia fall asleep in passive situations. This distinction affects which study you order and how you explain it to the payer.

Medical and medication history relevant to sleep: Hypertension, atrial fibrillation, GERD, and obesity all carry direct diagnostic weight for OSA. Opioids, benzodiazepines, and stimulants all affect study interpretation. Document these specifically, not as a generic list.

Physical exam findings for sleep medicine: Neck circumference (in centimeters), BMI, Mallampati score (I through IV), tonsillar hypertrophy grade, retrognathia, and nasal obstruction findings all contribute to the pre-test probability assessment. These are not optional for OSA evaluations.

Ordering rationale: State explicitly why you are ordering an in-lab PSG versus a home sleep apnea test (HSAT) versus a split-night study. The American Academy of Sleep Medicine (AASM) guidelines support HSAT for patients with high pre-test probability of moderate-to-severe OSA and no significant comorbidities; document when those criteria are or are not met.

Documenting the Polysomnography Interpretation Report

The PSG interpretation report is a distinct document from the visit note. Many practices treat it as a technical output from the scoring technician. Clinically and legally, the interpreting physician is responsible for every word.

A complete PSG interpretation report covers:

Study parameters and technical quality: Document recording time, total sleep time, and note any technical issues (electrode failures, artifact, patient events that affected data quality). If study quality was limited and data interpretation was affected, state this explicitly.

Sleep architecture: Report total sleep time (TST), sleep efficiency (TST divided by total recording time, expressed as a percentage), sleep onset latency, REM onset latency, and time spent in each sleep stage as both absolute minutes and percentage of TST. Compare to age-appropriate normative values when clinically relevant.

Respiratory findings: This is the core of OSA documentation. Report:

Apnea-Hypopnea Index (AHI) overall and broken down by sleep position and sleep stage
Separate counts for obstructive apneas, central apneas, mixed apneas, and hypopneas
Oxygen desaturation index (ODI), defining the desaturation threshold used (typically 3% or 4%)
Nadir oxygen saturation and time spent below 88% or 90% (payer-specific threshold)
Respiratory effort-related arousals (RERAs) and Respiratory Disturbance Index (RDI) if relevant
Positional data: AHI supine vs non-supine

Cardiac monitoring: Document cardiac rhythm findings, particularly any arrhythmias occurring in association with apneas. Bradycardia-tachycardia sequences in OSA are clinically significant and should be named.

Limb movements: Report the Periodic Limb Movement Index (PLMI), distinguishing movements with and without arousal. A PLMI above 15 with clinical symptoms may support a diagnosis of Periodic Limb Movement Disorder (PLMD).

Arousal index: The total arousal index and breakdown by cause (spontaneous, respiratory, limb movement-related) contextualizes sleep fragmentation.

Diagnostic impression and recommendations: State the diagnosis using DSM-5-TR or ICD-10 language. For OSA: G47.33 (Obstructive sleep apnea, adult) with severity (mild AHI 5-14, moderate AHI 15-29, severe AHI 30 or above). Include treatment recommendations with clinical rationale.

Fictional Example: PSG Report Impression Section

Dr. Elena Vargas, a 52-year-old woman referred for snoring and witnessed apneas, underwent a diagnostic PSG. The interpretation read:

"Technically adequate study (TST 402 min, SE 84%). AHI 38.4/hr overall (supine AHI 54.2/hr, lateral AHI 19.3/hr). Nadir SpO2 82%. Time below 90% SpO2: 41 minutes (6.1% of TST). 87 obstructive apneas, 4 central apneas, 12 mixed apneas, 178 hypopneas scored at 4% desaturation threshold. ODI (4%): 34.6/hr. PLMI: 6.4/hr without associated arousals. Total arousal index 42/hr (respiratory-related arousals predominant). Impression: Severe obstructive sleep apnea (G47.33), positionally influenced but not positionally dependent. PAP therapy indicated. Titration study or auto-PAP trial recommended."

This level of specificity is not excessive. It is what the record needs to justify both the diagnosis and the treatment order.

CPAP and BiPAP Titration Documentation

A CPAP titration study is a separate billable event from the diagnostic PSG, and its documentation must stand independently.

Pressure settings tested: Document the starting pressure, pressure increments, and the rationale for each adjustment. If auto-titrating PAP (APAP) was used, document the pressure range and algorithm parameters.

Response to titration: Report AHI and RDI at the final titration pressure or pressure range. Note residual events by type (residual centrals are particularly important if complex sleep apnea or treatment-emergent central sleep apnea emerged during titration).

Mask interface used: Document mask type (nasal, nasal pillow, full-face), any mask issues encountered, and patient tolerance. If mask replacement or interface change was required during the study, document why.

Final prescription: State the prescribed pressure or range explicitly, with equipment specifications sufficient for DME order generation.

For BiPAP (bilevel PAP) documentation, report IPAP and EPAP separately, the pressure support (IPAP minus EPAP), and the rationale for bilevel over CPAP (typically persistent hypercapnia, failed CPAP trial, or specific diagnosis such as obesity hypoventilation syndrome (OHS) or central sleep apnea).

Home Sleep Apnea Test (HSAT) Report Documentation

The HSAT report has similar interpretive requirements to the PSG report but with important caveats about what was and was not measured.

Device and channels recorded: Document the specific device used, the channels recorded (airflow, effort, oximetry, position at minimum), and whether the study was attended or unattended.

Study quality: HSAT has higher rates of technical failure than in-lab PSG. Document signal quality for each channel. If signal loss occurred, document the duration and its impact on the analysis.

AHI vs REI: HSAT devices do not record EEG, so sleep time is estimated rather than measured. The index reported is the Respiratory Event Index (REI), not the AHI. This distinction matters clinically and medicolegally. An REI of 15 on an HSAT may correspond to an in-lab AHI higher than 15, because denominators differ (recording time vs actual sleep time). State which index was used and what denominator was applied.

Diagnostic conclusion and limitations: If the HSAT is negative or borderline and clinical suspicion remains high, document the recommendation for in-lab PSG. CMS and most commercial payers accept HSAT for initial OSA diagnosis, but a negative HSAT in a high-probability patient requires documented clinical follow-up.

MSLT and MWT Documentation

The Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT) each have specific documentation requirements, and they are commonly misunderstood by coders and payers.

MSLT documentation: The MSLT measures physiological sleepiness. Document the number of nap opportunities completed (typically five, each separated by two hours), mean sleep latency (MSL) across all naps, and whether sleep-onset REM periods (SOREMPs) were observed and in how many naps. A preceding PSG is required for valid MSLT interpretation. Document that the preceding PSG was reviewed and that criteria for adequate prior sleep (at least six hours TST on the preceding PSG night) were met.

For narcolepsy type 1 (G47.411): MSL of 8 minutes or less plus two or more SOREMPs (including a SOREMP on the preceding PSG night if present).

For narcolepsy type 2 (G47.419): Same MSLT criteria without cataplexy documentation.

MWT documentation: The MWT measures ability to stay awake and is typically used to assess treatment efficacy or fitness for safety-sensitive occupations. Document the number of trials, trial duration (20-minute or 40-minute protocol), mean sleep latency, and the clinical question the test was ordered to address. A 40-minute MWT is preferred for occupational fitness determinations.

Follow-Up Visit Documentation for OSA

The follow-up visit for a patient on PAP therapy is where documentation gaps most commonly jeopardize DME continuation.

CMS requires documentation of PAP adherence at 31-90 days after initial setup for continued coverage. The standard threshold is PAP use for at least four hours per night on at least 70% of nights during any consecutive 30-day period in the first 90 days.

Download data review: Document the download date and the period it covers, then record:

Average usage hours per night (all nights, then nights used)
Percentage of nights with 4+ hours of use
Residual AHI or AHI on device (the AHI reported by the device, often labeled AHI or REI depending on manufacturer)
Leak data: median leak rate and percentage of time with large leak
Pressure percentile data (P50 and P95 pressures for APAP devices)

Symptom response: Document ESS score at follow-up and compare to baseline. Document whether witnessed apneas have resolved per bed partner report. Document changes in blood pressure if relevant (OSA treatment frequently results in measurable BP reduction).

Adherence barriers: If adherence is below threshold, document the barriers identified (mask discomfort, aerophagia, pressure intolerance, claustrophobia) and the interventions planned or implemented. This documentation is essential if you are requesting a coverage exception or transitioning to BiPAP.

Sleep Diary Integration Across Visit Types

Sleep diaries are a legitimate clinical instrument, not just a patient exercise. When patients submit completed diaries, document what the pattern showed, not just that the diary was reviewed.

For insomnia management (including CBT-I protocols), document:

Average sleep efficiency from diary data
Average total sleep time estimate
Sleep onset latency and wake after sleep onset (WASO) averages
Compliance with sleep restriction or stimulus control instructions

For circadian rhythm disorders, note the pattern (delayed phase, advanced phase, non-24-hour) and how diary data supports the clinical assessment.

DME Order Documentation and CMS Requirements

Durable medical equipment (DME) orders for PAP devices require specific documentation elements. Missing any of these is the most common reason for prior authorization denial or post-payment audit recoupment.

For initial CPAP/BiPAP orders under LCD L33718 (or the applicable MAC LCD for your region):

Diagnosis: ICD-10 code with documented AHI or REI severity meeting coverage criteria (AHI or REI of 15 or greater; or AHI or REI of 5-14 with documented symptoms including excessive daytime sleepiness, impaired cognition, mood disorders, insomnia, or relevant cardiovascular disease)
Study type and date: Whether PSG or HSAT was used, date performed, interpreting physician
Ordered equipment: Device type (CPAP, APAP, BiPAP), pressure settings or range, mask type and size
Face-to-face visit: Documentation of a face-to-face encounter within 30 days before or after the diagnostic study
Treating physician signature: Must be the physician who conducted the face-to-face encounter

For BiPAP, document the clinical rationale for upgrade from CPAP. Common accepted rationales include failed CPAP trial (with documented duration and adherence data), diagnosis of OHS, significant residual central apneas, or hypoventilation requiring pressure support.

Common Documentation Mistakes in Sleep Medicine

Reporting only total AHI without positional or stage breakdowns. Positional data affects treatment decisions and plan of care. A patient with AHI 22 overall but AHI 4 in lateral position may be a candidate for positional therapy rather than PAP.

Using HSAT AHI instead of REI. HSAT devices estimate REI, not AHI. Using the wrong term creates inconsistencies that flag during audit.

Incomplete titration reports that list only the final pressure. Payers and quality reviewers expect to see the titration arc: starting pressure, adjustments, response at each level, and rationale for the final prescription.

ESS scores without longitudinal comparison. A single ESS score is a snapshot. An ESS that dropped from 16 to 8 after PAP initiation is clinical evidence of treatment response. Document both values.

DME orders that do not match study results. The ordered pressure should correspond to the titrated pressure or fall within the APAP range established during titration. Discrepancies invite scrutiny.

Omitting adherence download data at follow-up. If the patient brings their device or you pull data remotely, document the actual numbers. "Patient reports using CPAP nightly" is not sufficient for CMS compliance.

Failing to document clinical rationale when ordering MSLT after PSG. The MSLT is not automatically indicated after every PSG. Document the clinical question: suspected narcolepsy, idiopathic hypersomnia, or insufficient sleep syndrome ruled out.

Practical Workflow Strategies

Sleep medicine practices that see high volumes of study interpretations face a specific documentation challenge: the PSG data is rich and structured, but the clinical interpretation layer takes time to write well, and it is the part that matters most for billing and legal protection.

Building visit-type-specific templates helps significantly. An initial consultation template, a PSG interpretation template, an HSAT interpretation template, a titration report template, and a PAP follow-up template each have distinct required fields. Practitioners who use NotuDocs for post-study documentation find that pre-built templates for each study type reduce the time spent on repetitive structure, leaving more cognitive room for the interpretation that only the clinician can provide.

The AASM's standardized terminology is worth adopting directly in your templates. Using consistent language across your documentation (AHI, RDI, REI, PLMI, MSL, SOREMP) reduces ambiguity in audit reviews and creates a cleaner longitudinal record.